111 related articles for article (PubMed ID: 11950788)
21. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2.
Walle UK; Galijatovic A; Walle T
Biochem Pharmacol; 1999 Aug; 58(3):431-8. PubMed ID: 10424761
[TBL] [Abstract][Full Text] [Related]
22. In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
Boutin JA; Meunier F; Lambert PH; Hennig P; Bertin D; Serkiz B; Volland JP
Drug Metab Dispos; 1993; 21(6):1157-66. PubMed ID: 7905399
[TBL] [Abstract][Full Text] [Related]
23. Glucuronidation of thyroxine in primary monolayer cultures of rat hepatocytes: in vitro induction of UDP-glucuronosyltranferases by methylcholanthrene, clofibrate, and dexamethasone alone and in combination.
Jemnitz K; Veres Z; Monostory K; Vereczkey L
Drug Metab Dispos; 2000 Jan; 28(1):34-7. PubMed ID: 10611137
[TBL] [Abstract][Full Text] [Related]
24. Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ.
Zhu YD; Guan XQ; Chen J; Peng S; Finel M; Zhao YY; Wang RM; Bi HC; Lei M; Wang DD; Ge GB
Front Pharmacol; 2020; 11():628314. PubMed ID: 33628187
[TBL] [Abstract][Full Text] [Related]
25. Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA.
Liu X; Tam VH; Hu M
Mol Pharm; 2007; 4(6):873-82. PubMed ID: 17927138
[TBL] [Abstract][Full Text] [Related]
26. Mutual regioselective inhibition of human UGT1A1-mediated glucuronidation of four flavonoids.
Ma G; Wu B; Gao S; Yang Z; Ma Y; Hu M
Mol Pharm; 2013 Aug; 10(8):2891-903. PubMed ID: 23786524
[TBL] [Abstract][Full Text] [Related]
27. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
[TBL] [Abstract][Full Text] [Related]
28. Increase in rat liver UDP-glucuronosyltransferase mRNA by microsomal enzyme inducers that enhance thyroid hormone glucuronidation.
Vansell NR; Klaassen CD
Drug Metab Dispos; 2002 Mar; 30(3):240-6. PubMed ID: 11854140
[TBL] [Abstract][Full Text] [Related]
29. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro.
Malfatti MA; Felton JS
Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245
[TBL] [Abstract][Full Text] [Related]
30. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
Watanabe Y; Nakajima M; Yokoi T
Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of flavonoids on sulfo- and glucurono-conjugation of acetaminophen in rat cultured hepatocytes and liver subcellular preparations.
Morimitsu Y; Sugihara N; Furuno K
Biol Pharm Bull; 2004 May; 27(5):714-7. PubMed ID: 15133252
[TBL] [Abstract][Full Text] [Related]
32. The use of a high-volume screening procedure to assess the effects of dietary flavonoids on human cyp1a1 expression.
Allen SW; Mueller L; Williams SN; Quattrochi LC; Raucy J
Drug Metab Dispos; 2001 Aug; 29(8):1074-9. PubMed ID: 11454723
[TBL] [Abstract][Full Text] [Related]
33. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability.
Wen X; Walle T
Drug Metab Dispos; 2006 Oct; 34(10):1786-92. PubMed ID: 16868069
[TBL] [Abstract][Full Text] [Related]
34. Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes.
Mano Y; Usui T; Kamimura H
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):211-4. PubMed ID: 17697043
[TBL] [Abstract][Full Text] [Related]
35. Acyl-glucuronide as a Possible Cause of Trovafloxacin-Induced Liver Toxicity: Induction of Chemokine (C-X-C Motif) Ligand 2 by Trovafloxacin Acyl-glucuronide.
Mitsugi R; Sumida K; Fujie Y; Tukey RH; Itoh T; Fujiwara R
Biol Pharm Bull; 2016; 39(10):1604-1610. PubMed ID: 27725437
[TBL] [Abstract][Full Text] [Related]
36. Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines.
Wang W; VanAlstyne PC; Irons KA; Chen S; Stewart JW; Birt DF
Nutr Cancer; 2004; 48(1):106-14. PubMed ID: 15203384
[TBL] [Abstract][Full Text] [Related]
37. Species- and gender-dependent differences in the glucuronidation of a flavonoid glucoside and its aglycone determined using expressed UGT enzymes and microsomes.
Dai P; Luo F; Wang Y; Jiang H; Wang L; Zhang G; Zhu L; Hu M; Wang X; Lu L; Liu Z
Biopharm Drug Dispos; 2015 Dec; 36(9):622-35. PubMed ID: 26317684
[TBL] [Abstract][Full Text] [Related]
38. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M
Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488
[TBL] [Abstract][Full Text] [Related]
39. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
Yoder Graber AL; Ramírez J; Innocenti F; Ratain MJ
Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships of the glucuronidation of flavonoids by human glucuronosyltransferases.
Wong YC; Zhang L; Lin G; Zuo Z
Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1399-419. PubMed ID: 19663742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
